NCT06714747

Brief Summary

The role of orthognathic surgery in the correction of dento-skeletal dysmorphies, whether they are Class II or Class III or asymmetries, is to improve both the function and aesthetic appearance of thepatient. Both aspects are equally important to achieve optimal results. When the surgeon plans the surgery, he or she must therefore take into account the effects that bone displacements will have at the level of the soft tissues directly involved in the surgery, such as the maxilla and mandible. Traditionally, such surgery consists of an orthodontic presurgical phase1,2 .

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
6mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Jan 2022Nov 2026

Study Start

First participant enrolled

January 11, 2022

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

November 28, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2026

Last Updated

December 4, 2024

Status Verified

October 1, 2024

Enrollment Period

4.7 years

First QC Date

November 28, 2024

Last Update Submit

December 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • primary outcomes

    Implementation of a virtual three-dimensional model of the face already provided for care procedure that is anatomically accurate in predicting soft tissue displacements following orthognathic surgery. This model will include the biomechanical characteristics of the facial muscles and skin. In particular, the sensitivities of different areas of the face (nose, cheeks, and upper lip) that are particularly important in orthognathic surgery will be evaluated in response to variation in the biomechanical properties of the muscles (Poisson's coefficient and Young's modulus).

    18 months

Secondary Outcomes (1)

  • secondary outcomes

    18 months

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Verranno arruolati 10 pazienti retrospettivamente. Per ogni paziente verranno effettuate 27 simulazioni virtuali variando le proprietà biomeccaniche delle singole parti. I dati verranno perciò analizzati su 270 interventi virtuali. Le 27 simulazioni procapite vengono determinate in base al range di variazione che in fase iniziale si decide di dare ai vari parametri biomeccanici presi in considerazione per ogni componente del modello (tessuti molli, muscoli, osso)14 . Un campione di 270 simulazione, consente di avere un intervallo di confidenza di 7.85 e un livello di confidenza del 99%. La tabella di seguito dimostra i valori massimi e minimi dati ai singoli muscoli per quanto riguarda il modulo di Young o modulo di elasticità.

You may qualify if:

  • Patients undergoing orthognathic surgery and preoperative radiographic study with CBCT and MRI
  • Patients with age \> or = 18 years old
  • Obtaining informed consent
  • Patients with preoperative teleradiography and orthopantomography

You may not qualify if:

  • patients with cleft lip-palate, facial malformations and/or syndromes (syndromes with involvement of the cephalic extremity, such as sd of Apert. Cropuzon, Ofeiffer, Treacher Collins)
  • patients who have undergone application of Medpor prostheses or who have undergone ancillary procedures (lipofilling, fillers, volumetric facial augmentations with insertion of polyethylene ketone prostheses)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS - Azienda Ospedaliero Universitaria di Bologna

Bologna, Emilia-Romagna, 40138, Italy

RECRUITING

Study Officials

  • Claudio Marchetti, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Claudio Marchetti, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2024

First Posted

December 4, 2024

Study Start

January 11, 2022

Primary Completion (Estimated)

September 11, 2026

Study Completion (Estimated)

November 11, 2026

Last Updated

December 4, 2024

Record last verified: 2024-10

Locations